We are live on ! Find out more
BTW

Boston Trust Walden Portfolio holdings

AUM $12.2B
1-Year Est. Return 12.45%
This Fund
S&P 500
This Quarter Est. Return
+3.09%
1 Year Est. Return
+12.45%
3 Year Est. Return
+44.66%
5 Year Est. Return
+68.67%
10 Year Est. Return
+295.88%
AUM
$6.42B
AUM Growth
+$199M
Cap. Flow
+$34.8M
Cap. Flow %
0.54%
Top 10 Hldgs %
16.84%
Holding
385
New
15
Increased
156
Reduced
158
Closed
12

Top Buys

Rank Stock Value
1
EL icon
Estee Lauder
EL
+$23M
2
DHR icon
Danaher
DHR
+$18.9M
3
MZTI
The Marzetti Company
MZTI
+$16.2M
4
MRSH
Marsh
MRSH
+$15.8M
5
CUBE icon
CubeSmart
CUBE
+$14M

Sector Composition

Rank Sector Weight
1 Financials 19.49%
2 Healthcare 15.61%
3 Technology 14.64%
4 Industrials 12.9%
5 Consumer Discretionary 8.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CVX icon
126
Chevron
CVX
$373B
$16.4M 0.25%
139,327
-7,052
-5% -$770K
MZTI
127
The Marzetti Company
MZTI
$2.94B
$16.1M 0.25%
+134,349
New +$16.2M
MLKN icon
128
MillerKnoll
MLKN
$1.49B
$15.9M 0.25%
443,187
+126,224
+40% +$4.25M
HUBG icon
129
HUB Group
HUBG
$3.13B
$15.5M 0.24%
723,106
-4,044
-0.6% -$77.2K
CMA
130
DELISTED
Comerica
CMA
$15M 0.23%
196,319
-930
-0.5% -$66.6K
ANIK icon
131
Anika Therapeutics
ANIK
$203M
$14.9M 0.23%
257,278
-4,714
-2% -$246K
ACH
132
Accendra Health
ACH
$266M
$14.8M 0.23%
506,011
-127,773
-20% -$3.77M
CUBE icon
133
CubeSmart
CUBE
$9.48B
$14.7M 0.23%
+567,458
New +$14M
EXLS icon
134
EXL Service
EXLS
$4.3B
$14.7M 0.23%
1,256,150
+59,875
+5% +$671K
CTSH icon
135
Cognizant
CTSH
$21.2B
$14.3M 0.22%
197,057
-21,290
-10% -$1.5M
AWR icon
136
American States Water
AWR
$3.5B
$14.3M 0.22%
290,034
-2,343
-0.8% -$116K
MKC icon
137
McCormick & Company Non-Voting
MKC
$13.9B
$14.3M 0.22%
278,294
+1,560
+0.6% +$75.2K
MTX icon
138
Minerals Technologies
MTX
$2.32B
$14.2M 0.22%
200,492
-1,816
-0.9% -$124K
ALV icon
139
Autoliv
ALV
$8.8B
$14.2M 0.22%
159,012
-29,673
-16% -$2.41M
FET icon
140
Forum Energy Technologies
FET
$593M
$14M 0.22%
44,138
-340
-0.8% -$91.1K
WAFD icon
141
WaFd
WAFD
$2.82B
$13.9M 0.22%
414,438
-4,252
-1% -$138K
HE icon
142
Hawaiian Electric Industries
HE
$2.32B
$13.7M 0.21%
+410,942
New +$13.6M
NDSN icon
143
Nordson
NDSN
$16.1B
$13.5M 0.21%
114,028
+12,417
+12% +$1.48M
TMP icon
144
Tompkins Financial
TMP
$1.35B
$13.4M 0.21%
155,742
+28,375
+22% +$2.21M
HAE icon
145
Haemonetics
HAE
$3.54B
$13.2M 0.21%
294,791
-4,806
-2% -$200K
INVX
146
Innovex International
INVX
$1.8B
$13.2M 0.21%
298,390
-7,732
-3% -$336K
LKFN icon
147
Lakeland Financial Corp
LKFN
$1.56B
$13.1M 0.2%
269,865
-3,600
-1% -$163K
IFF icon
148
International Flavors & Fragrances
IFF
$20B
$13.1M 0.2%
91,834
+412
+0.5% +$56.5K
UI icon
149
Ubiquiti
UI
$33B
$13.1M 0.2%
232,980
-5,168
-2% -$298K
IPCC
150
DELISTED
Infinity Property & Casualty C
IPCC
$13M 0.2%
137,852
-2,190
-2% -$203K

Similar funds

Boston Trust Walden's Q3 2017 Portfolio in Review

As of Q3 2017, Boston Trust Walden held 385 positions worth $6.42B, up 3.2% from $6.22B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Boston Trust Walden's Q3 2017 filing shows 15 new, 156 increased, 158 reduced and 12 closed positions. Its largest new stake was The Marzetti Company: 134,349 shares worth $16.1M. The largest sale was IPG Photonics, an estimated $23.2M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 19% a quarter earlier, followed by Healthcare and Technology.

  • Boston Trust Walden's largest Q3 2017 buy was The Marzetti Company: 134,349 shares worth $16.1M.
  • Boston Trust Walden added most to Estee Lauder in Q3 2017, an estimated $23M increase.
  • Boston Trust Walden's biggest Q3 2017 reduction was IPG Photonics, cutting an estimated $23.2M.
  • Boston Trust Walden fully exited Parexel International Corp in Q3 2017, selling an estimated $22.7M.
  • Boston Trust Walden's ten largest holdings make up 17% of its $6.42B portfolio in Q3 2017.
  • Boston Trust Walden opened 15 new positions and closed 12 in Q3 2017.
  • Boston Trust Walden's portfolio value rose 3.2% quarter-over-quarter to $6.42B.

Based on Boston Trust Walden's 13F filing for Q3 2017, filed 13 Oct 2017.